Physician profile
Alex Lambi
NPI 1578941159
$3,474.00
in general payments reported to CMS, 2019-2025
13 companies · $786 in 2025
The $786 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,777 · 2020: $153 · 2021: $32.12 · 2022: $195 · 2023: $310 · 2024: $221 · 2025: $786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $691 · Food and Beverage: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $691.37 |
| Food and Beverage | $625.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,712.03 | 2019-2025 | Na |
| Skeletal Dynamics INC | $691.37 | 2025 | Geminus, Align, Implate |
| Axogen | $346.35 | 2020-2024 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Acera Surgical, INC. | $159.37 | 2023 | Restrata Wound Matrix |
| Kci USA, INC. | $130.89 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $124.92 | 2023 | Xiaflex |
| Musculoskeletal Transplant Foundation INC. | $112.48 | 2019-2022 | |
| Checkpoint Surgical, INC | $70.54 | 2024 | Checkpoint Stimulators |
| Mentor Worldwide LLC | $35.48 | 2019 | |
| Integra Lifesciences Corporation | $35.18 | 2019-2022 | |
| Acell, INC. | $22.30 | 2019 | |
| Allergan, INC. | $19.43 | 2020 | |
| Medline Industries LP | $13.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Lambi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.